1. Growth factors: avenues for the treatment of myocardial infarction and potential delivery strategies
   Demin Li et al, 2022, Regenerative Medicine CrossRef
2. Serum levels of neuregulin-1 in patients with coronary artery disease: clinical and pathogenetic aspects
   E. A. Zakharyan et al, 2024, Cardiovascular Therapy and Prevention CrossRef
3. Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
   Chin-Feng Hsuan et al, 2023, Biomedicines CrossRef
4. Is neuregulin-1 (NRG-1) a potential blood biomarker linking depression to obesity? A case-control study
   Heba Ahmed Abdelaziz et al, 2023, BMC Psychiatry CrossRef
5. Neuregulin-1, a potential therapeutic target for cardiac repair
   Yan Wang et al, 2022, Frontiers in Pharmacology CrossRef
6. Diagnostic and therapeutic aspects of neuregulin-1: A review
   Amina M. Alieva et al, 2023, Medical Journal of the Russian Federation CrossRef
7. From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction
   Cristian Stătescu et al, 2022, International Journal of Molecular Sciences CrossRef
8. Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects
   Junyu Xu et al, 2023, American Journal of Cardiovascular Drugs CrossRef
9. Metformin alleviates ethanol-induced cardiomyocyte injury by activating AKT/Nrf2 signaling in an ErbB2-dependent manner
   Yunjie Chen et al, 2023, Molecular Biology Reports CrossRef